
Brookdale Senior (BKD) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
812.9M
Gross Profit
215.9M
26.56%
Operating Income
15.4M
1.90%
Net Income
-43.0M
-5.29%
EPS (Diluted)
$-0.18
Balance Sheet Metrics
Total Assets
6.2B
Total Liabilities
6.1B
Shareholders Equity
148.1M
Debt to Equity
40.89
Cash Flow Metrics
Operating Cash Flow
27.9M
Free Cash Flow
-18.4M
Revenue & Profitability Trend
Brookdale Senior Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 3.1B | 3.0B | 2.7B | 2.7B | 3.4B |
Cost of Goods Sold | 2.3B | 2.3B | 2.2B | 2.3B | 2.7B |
Gross Profit | 799.3M | 737.6M | 513.9M | 488.6M | 681.4M |
Gross Margin % | 25.6% | 24.5% | 18.7% | 17.8% | 19.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 386.4M | 381.3M | 333.9M | 359.3M | 430.6M |
Other Operating Expenses | - | -9.1M | -80.5M | -12.4M | -115.7M |
Total Operating Expenses | 386.4M | 372.2M | 253.4M | 346.9M | 314.9M |
Operating Income | 55.1M | 22.7M | -86.9M | -195.9M | 7.3M |
Operating Margin % | 1.8% | 0.8% | -3.2% | -7.1% | 0.2% |
Non-Operating Items | |||||
Interest Income | 19.2M | 23.1M | 6.9M | 1.3M | 4.8M |
Interest Expense | 243.3M | 231.7M | 205.9M | 187.7M | 208.8M |
Other Non-Operating Income | -18.6M | 13.3M | 52.5M | 282.0M | 284.0M |
Pre-tax Income | -197.3M | -180.3M | -239.9M | -107.5M | 87.3M |
Income Tax | 4.6M | 8.8M | -1.6M | -8.2M | 5.4M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 6.1% |
Net Income | -202.0M | -189.1M | -238.3M | -99.4M | 81.9M |
Net Margin % | -6.5% | -6.3% | -8.7% | -3.6% | 2.4% |
Key Metrics | |||||
EBITDA | 441.5M | 406.2M | 268.8M | 159.3M | 381.3M |
EPS (Basic) | $-0.89 | $-0.84 | $-1.25 | $-0.54 | $0.45 |
EPS (Diluted) | $-0.89 | $-0.84 | $-1.25 | $-0.54 | $0.44 |
Basic Shares Outstanding | 227525000 | 225209000 | 190463000 | 184975000 | 183498000 |
Diluted Shares Outstanding | 227525000 | 225209000 | 190463000 | 184975000 | 183498000 |
Income Statement Trend
Brookdale Senior Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 308.9M | 278.0M | 398.8M | 347.0M | 380.4M |
Short-term Investments | 19.9M | 29.8M | 48.7M | 182.4M | 172.9M |
Accounts Receivable | 51.9M | 48.4M | 55.8M | 51.1M | 109.2M |
Inventory | - | - | - | - | - |
Other Current Assets | 92.4M | 80.9M | 106.1M | 87.9M | 66.9M |
Total Current Assets | 512.9M | 478.4M | 637.1M | 699.0M | 773.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.4B | 1.7B | 2.0B | 2.2B | 2.3B |
Goodwill | 54.6M | 54.6M | 54.6M | 54.6M | 308.3M |
Intangible Assets | - | - | - | - | 34.1M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 67.1M | 64.3M | 84.5M | 82.0M | 112.9M |
Total Non-Current Assets | 5.8B | 5.1B | 5.3B | 5.7B | 6.1B |
Total Assets | 6.3B | 5.6B | 5.9B | 6.4B | 6.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 65.5M | 66.5M | 71.0M | 76.1M | 71.2M |
Short-term Debt | 188.9M | 235.2M | 266.9M | 233.9M | 234.7M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 579.8M | 600.1M | 641.2M | 632.0M | 690.7M |
Non-Current Liabilities | |||||
Long-term Debt | 5.5B | 4.5B | 4.6B | 5.0B | 5.2B |
Deferred Tax Liabilities | 9.6M | 6.0M | 0 | 0 | 9.6M |
Other Non-Current Liabilities | 69.2M | 71.7M | 85.8M | 86.8M | 188.4M |
Total Non-Current Liabilities | 5.5B | 4.6B | 4.7B | 5.1B | 5.4B |
Total Liabilities | 6.1B | 5.2B | 5.4B | 5.7B | 6.1B |
Equity | |||||
Common Stock | 2.1M | 2.0M | 2.0M | 2.0M | 2.0M |
Retained Earnings | -4.0B | -3.8B | -3.6B | -3.4B | -3.3B |
Treasury Stock | 102.8M | 102.8M | 102.8M | 102.8M | 102.8M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 213.9M | 405.2M | 584.2M | 699.6M | 802.7M |
Key Metrics | |||||
Total Debt | 5.7B | 4.7B | 4.9B | 5.2B | 5.4B |
Working Capital | -66.8M | -121.7M | -4.1M | 67.0M | 82.9M |
Balance Sheet Composition
Brookdale Senior Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -202.0M | -189.1M | -238.3M | -99.4M | 81.9M |
Depreciation & Amortization | 367.5M | 350.4M | 353.9M | 344.9M | 365.7M |
Stock-Based Compensation | 14.2M | 12.0M | 14.5M | 16.3M | 20.7M |
Working Capital Changes | 18.1M | 16.6M | 5.2M | 9.0M | 109.1M |
Operating Cash Flow | 144.1M | 130.0M | 89.6M | 232.8M | 428.9M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | 0 | -7.6M | -218.0K | -5.4M | -4.1M |
Investment Purchases | -59.2M | -186.9M | -265.3M | -362.3M | -378.3M |
Investment Sales | 80.6M | 207.0M | 399.5M | 353.0M | 275.0M |
Investing Cash Flow | -76.8M | 119.8M | 128.5M | 321.0M | -239.2M |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | -18.1M |
Dividends Paid | 0 | 0 | 0 | 0 | - |
Debt Issuance | 765.7M | 205.5M | 254.3M | 353.0M | 963.1M |
Debt Repayment | -595.0M | -367.2M | -281.2M | -441.6M | -705.2M |
Financing Cash Flow | 167.2M | -163.6M | 107.5M | -93.8M | 216.5M |
Free Cash Flow | -35.1M | -70.3M | -193.6M | -271.3M | 19.8M |
Net Change in Cash | 234.5M | 86.3M | 325.5M | 459.9M | 406.2M |
Cash Flow Trend
Brookdale Senior Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-8.21
Forward P/E
-12.18
Price to Book
16.46
Price to Sales
0.57
PEG Ratio
-1.40
Profitability Ratios
Profit Margin
-7.95%
Operating Margin
3.34%
Return on Equity
-108.24%
Return on Assets
0.88%
Financial Health
Current Ratio
0.83
Debt to Equity
5,198.71
Beta
0.88
Per Share Data
EPS (TTM)
$-1.05
Book Value per Share
$0.44
Revenue per Share
$13.23
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
bkd | 1.7B | -8.21 | 16.46 | -108.24% | -7.95% | 5,198.71 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 1.9B | 13.80 | 0.62 | 4.83% | 4.31% | 74.74 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Pacs | 1.8B | 19.41 | 3.15 | 110.96% | 2.59% | 469.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.